Enables additional US manufacturing capacity to serve increased demand for pharma/biotech customers
Godavari Biorefineries receives patent from CNIPA
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
Finerenone significantly reduced the combined risk of cardiovascular death and total (first and recurrent) heart failure events,
The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
Celecoxib is a nonsteroidal anti-inflammatory drug
Milestone also announced the extension of its $75 million Royalty Purchase Agreement with RTW Investments
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
The agency concluded that for people of all ages, IXCHI should be administered when there is a significant risk of chikungunya infection
Subscribe To Our Newsletter & Stay Updated